Sinclair Pharma Stock Price, News & Analysis (LON:SPH)

GBX 26 -0.25 (-0.95 %)
(As of 12/14/2017 04:00 PM ET)
Previous CloseGBX 26
Today's RangeGBX 25.75 - GBX 26.56
52-Week RangeGBX 25 - GBX 36.35
Volume61,704 shs
Average Volume142,557 shs
Market Capitalization£133.50 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Sinclair Pharma (LON:SPH)

Sinclair Pharma logoSinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor. The Company's product categories include Aesthetic Care, Skin Care, Wound Care and Non-Dermatology. The Company provides aesthetic dermatology solutions through thread lift, collagen stimulation and dermal fillers. The Company's aesthetic products include Silhouette Soft, Ellanse, Perfectha, Sculptra and USOFT Massage Gel. Its Silhouette Soft is inserted in the subcutaneous tissue. Its USOFT Massage Gel is a gel used for facial massage. It is engaged in research and development, and owns various product rights and licenses in a range of territories in which it trades.

Receive SPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Generic Pharmaceuticals
Sub-IndustryN/A
SectorGeneric Pharmaceuticals
SymbolLON:SPH
CUSIPN/A
Phone+44-20-74676920

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.03)
Net IncomeN/A
Net Margins-35.58%
Return on Equity-14.73%
Return on Assets-8.12%

Miscellaneous

EmployeesN/A
Outstanding Shares503,770,000

Sinclair Pharma (LON:SPH) Frequently Asked Questions

What is Sinclair Pharma's stock symbol?

Sinclair Pharma trades on the London Stock Exchange (LON) under the ticker symbol "SPH."

Where is Sinclair Pharma's stock going? Where will Sinclair Pharma's stock price be in 2017?

5 brokers have issued twelve-month price objectives for Sinclair Pharma's shares. Their predictions range from GBX 35 to GBX 71. On average, they expect Sinclair Pharma's share price to reach GBX 53.20 in the next year. View Analyst Ratings for Sinclair Pharma.

Who are some of Sinclair Pharma's key competitors?

Who are Sinclair Pharma's key executives?

Sinclair Pharma's management team includes the folowing people:

  • Christopher P. Spooner, Chief Executive Officer, Executive Director (Age 44)
  • Alan Olby, Chief Financial Officer
  • Jean-Louis Lamande, Operations Finance Director
  • Jayne Burrell, Group General Counsel, Company Secretary
  • Patrick Khoukaz, Head - European Operations and Global Aesthetics
  • Sarb Klair, Head - Corporate Development
  • Nairn McMaster, Head - Business Development
  • Grahame David Cook, Non-Executive Independent Chairman of the Board (Age 58)
  • Jean-Charles Tschudin, Senior Non-Executive Independent Director (Age 72)

How do I buy Sinclair Pharma stock?

Shares of Sinclair Pharma and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sinclair Pharma's stock price today?

One share of Sinclair Pharma stock can currently be purchased for approximately GBX 26.

How big of a company is Sinclair Pharma?

Sinclair Pharma has a market capitalization of £133.50 million.

How can I contact Sinclair Pharma?

Sinclair Pharma's mailing address is 1st Fl Whitfield Court, 30-32 Whitfield Street, LONDON, W1T 2RQ, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-20-74676920.


MarketBeat Community Rating for Sinclair Pharma (SPH)

Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  320 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  417
MarketBeat's community ratings are surveys of what our community members think about Sinclair Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sinclair Pharma (LON:SPH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.862.862.862.86
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 54GBX 54GBX 54GBX 54

Sinclair Pharma (LON:SPH) Consensus Price Target History

Price Target History for Sinclair Pharma (LON:SPH)

Sinclair Pharma (LON:SPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/31/2017Peel HuntReiterated RatingBuyGBX 68View Rating Details
9/29/2017Jefferies GroupReiterated RatingBuyGBX 55View Rating Details
9/19/2017N+1 SingerReiterated RatingBuyGBX 37View Rating Details
7/11/2017Stifel NicolausReiterated RatingBuyGBX 71View Rating Details
4/4/2017Numis SecuritiesReiterated RatingHoldGBX 35View Rating Details
11/18/2016Canaccord GenuityReiterated RatingBuyGBX 58View Rating Details
9/15/2016Royal Bank of CanadaReiterated RatingOutperformView Rating Details
(Data available from 12/14/2015 forward)

Earnings

Earnings History for Sinclair Pharma (LON:SPH)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Sinclair Pharma (LON:SPH) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sinclair Pharma (LON:SPH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Sinclair Pharma (LON SPH) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Sinclair Pharma (LON:SPH)

Sinclair Pharma (LON SPH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2016Alan OlbyInsiderBuy6,748GBX 29£1,956.92
10/4/2016Jeff ThompsonInsiderBuy150,000GBX 29£43,500
5/27/2016Tschudin,Jean-CharlesInsiderBuy97,000GBX 36£34,920
5/26/2016Tschudin,Jean-CharlesInsiderBuy3,023GBX 35£1,058.05
5/23/2016Olby,AlanInsiderBuy50,000GBX 35£17,500
5/20/2016Foucher,ChristopheInsiderBuy31,500GBX 35£11,025
(Data available from 1/1/2013 forward)

Headlines

Sinclair Pharma (LON SPH) News Headlines

Source:
DateHeadline
Sinclair Pharma Plc – Value Analysis (LONDON:SPH) : December 4, 2017Sinclair Pharma Plc – Value Analysis (LONDON:SPH) : December 4, 2017
finance.yahoo.com - December 4 at 3:48 PM
Sinclair Pharma Plc breached its 50 day moving average in a Bearish Manner : SPH-GB : December 1, 2017Sinclair Pharma Plc breached its 50 day moving average in a Bearish Manner : SPH-GB : December 1, 2017
finance.yahoo.com - December 1 at 6:24 PM
Sinclair Pharma PLC (SPH) Receives Consensus Recommendation of "Buy" from AnalystsSinclair Pharma PLC (SPH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 12 at 5:46 AM
Sinclair Pharma Plc breached its 50 day moving average in a Bullish Manner : SPH-GB : October 23, 2017Sinclair Pharma Plc breached its 50 day moving average in a Bullish Manner : SPH-GB : October 23, 2017
finance.yahoo.com - October 23 at 6:34 AM
Sinclair Pharma PLC (SPH) Given Average Recommendation of "Buy" by AnalystsSinclair Pharma PLC (SPH) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - October 18 at 10:10 AM
Sinclair Pharma Plc :SPH-GB: Earnings Analysis: For the six months ended June 30, 2017 : October 9, 2017Sinclair Pharma Plc :SPH-GB: Earnings Analysis: For the six months ended June 30, 2017 : October 9, 2017
finance.yahoo.com - October 10 at 7:03 AM
Sinclair Pharma Plc :SPH-GB: Earnings Analysis: For the six months ended June 30, 2017 : October 9, 2017Sinclair Pharma Plc :SPH-GB: Earnings Analysis: For the six months ended June 30, 2017 : October 9, 2017
finance.yahoo.com - October 10 at 7:03 AM
Sinclair Pharma PLCs (SPH) "Buy" Rating Reiterated at Jefferies Group LLCSinclair Pharma PLC's (SPH) "Buy" Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - September 29 at 7:18 PM
Sinclair Pharma PLC (SPH) Given Buy Rating at Peel HuntSinclair Pharma PLC (SPH) Given Buy Rating at Peel Hunt
www.americanbankingnews.com - September 24 at 5:20 PM
Sinclair Pharma PLC (SPH) Stock Rating Reaffirmed by N+1 SingerSinclair Pharma PLC (SPH) Stock Rating Reaffirmed by N+1 Singer
www.americanbankingnews.com - September 24 at 3:24 PM
Sinclair Pharma PLC (SPH) Receives Consensus Rating of "Buy" from AnalystsSinclair Pharma PLC (SPH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - September 23 at 6:52 AM
Sinclair Pharma HY Loss Widens; On Track To Meet FY Guidance For EBITDA ProfitSinclair Pharma HY Loss Widens; On Track To Meet FY Guidance For EBITDA Profit
www.rttnews.com - September 19 at 7:56 AM
Why Sinclair Pharma plc (AIM:SPH) Could Be A BuyWhy Sinclair Pharma plc (AIM:SPH) Could Be A Buy
finance.yahoo.com - September 14 at 10:29 AM
Sinclair Pharma PLC (SPH) Scheduled to Post Earnings on TuesdaySinclair Pharma PLC (SPH) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - September 12 at 1:34 AM
Sinclair Pharma PLC (SPH) Given Consensus Rating of "Buy" by BrokeragesSinclair Pharma PLC (SPH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 29 at 6:44 AM
Sinclair Pharma PLC (SPH) Receives Consensus Rating of "Buy" from BrokeragesSinclair Pharma PLC (SPH) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - August 4 at 6:50 AM
Can these growth shares provide high total returns?Can these growth shares provide high total returns?
www.fool.co.uk - July 12 at 1:36 AM
Sinclair Pharma Silhouette Soft Product Drives Half Year Revenue RiseSinclair Pharma Silhouette Soft Product Drives Half Year Revenue Rise
www.morningstar.co.uk - July 12 at 1:36 AM
Sinclair Pharma H1 Sales Climb; Says Confident Of Adj. EBITDA Profit For FYSinclair Pharma H1 Sales Climb; Says Confident Of Adj. EBITDA Profit For FY
www.rttnews.com - July 11 at 7:55 AM
Sinclair Pharma Loss Narrows; Sees Positive FY17 EBITDA; Settles With AllianceSinclair Pharma Loss Narrows; Sees Positive FY17 EBITDA; Settles With Alliance
www.rttnews.com - March 21 at 10:09 AM
BUZZ-Alliance Pharma: gains on deal settlementBUZZ-Alliance Pharma: gains on deal settlement
uk.finance.yahoo.com - March 21 at 10:09 AM
Full Year 2016 Sinclair Pharma PLC Earnings Release - Before Market OpenFull Year 2016 Sinclair Pharma PLC Earnings Release - Before Market Open
biz.yahoo.com - March 21 at 10:09 AM
Pre-Close Trading Update - London South East (registration) (blog)Pre-Close Trading Update - London South East (registration) (blog)
www.lse.co.uk - January 18 at 2:46 AM
Sinclair Pharma H1 Revenues Surge; Affirms 2016 Outlook - Quick FactsSinclair Pharma H1 Revenues Surge; Affirms 2016 Outlook - Quick Facts
www.nasdaq.com - July 19 at 7:43 PM
Director dealings: Jardine Mathesons Keswick sells sharesDirector dealings: Jardine Matheson's Keswick sells shares
uk.finance.yahoo.com - May 23 at 1:18 PM
Don’t buy or sell Sinclair Pharma plc, Ladbrokes plc or Close Brothers Group plc until you’ve read this!Don’t buy or sell Sinclair Pharma plc, Ladbrokes plc or Close Brothers Group plc until you’ve read this!
uk.finance.yahoo.com - May 20 at 6:20 AM
Should You Buy Cap-XX Limited, Sinclair Pharma PLC And Manx Telecom PLC After Todays Results? - Motley Fool UKShould You Buy Cap-XX Limited, Sinclair Pharma PLC And Manx Telecom PLC After Today's Results? - Motley Fool UK
www.fool.co.uk - March 30 at 2:36 PM
Half Year 2016 Sinclair Pharma PLC Earnings Release - Before Market OpenHalf Year 2016 Sinclair Pharma PLC Earnings Release - Before Market Open
biz.yahoo.com - March 30 at 7:07 AM

SEC Filings

Sinclair Pharma (LON:SPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Sinclair Pharma (LON SPH) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.